Streetbeat News

Earnings

MIRA

Mira Pharmaceuticals reported Q4 earnings with losses of $(0.19) per share, surpassing the analyst consensus estimate of $(0.23) by 17.39%.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:54 am

GUTS

Fractyl Health (NASDAQ:GUTS) reported a Q4 adjusted EPS loss of $(8.02), an 8.53% increase in losses compared to $(7.39) per share YoY. Sales for the quarter were $7.00 thousand.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:53 am

VTSI

VirTra shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:52 am

XLO

Xilio Therapeutics shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:52 am

TSLA

Tesla Inc.'s sales of China-made vehicles increased by nearly 48% in March compared to February, with a total of 89,064 units sold. Despite this monthly increase, the sales were flat compared to March 2023. For Q1, Tesla delivered 220,681 China-made cars, with analyst Gary Black estimating a total of 133,700 EVs sold in China for the quarter, marking a 2% year-over-year decline and a 22.2% drop from the previous quarter. Tesla's global deliveries for the quarter are expected to be around 431,000 units, potentially marking the first year-over-year decline since 2020. Tesla's stock fell 0.55% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

April 02, 2024 | 11:51 am

ALZN

AZTR

GANX

SILO

Insiders at Alzamend Neuro, Gain Therapeutics, Azitra, and Silo Pharma have recently made significant stock purchases. These transactions come amidst various developments within the companies, such as FDA approvals, executive appointments, financial results, and successful studies, indicating insider confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

April 02, 2024 | 11:39 am

ASTS

AST SpaceMobile's shares dropped following the announcement of Q4 earnings per share (EPS) results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:32 am

GOEV

PVH

QQQ

SPY

U.S. stocks are poised for a lower open amid concerns over interest rates and economic data. Strong manufacturing data has led to mixed market reactions, with major indices like the DJIA and S&P 500 closing lower. Analysts remain optimistic about the tech sector despite fears of overvaluation. Futures trading indicates a negative start, with SPY and QQQ ETFs down in premarket. Companies like PVH Corp. and Canoo, Inc. reported earnings, leading to significant premarket drops. Health insurance stocks also fell sharply due to concerns over Medicare Advantage program payments.

Portfolio Pulse from Shanthi Rexaline

April 02, 2024 | 11:24 am

MEG

Montrose Environmental Group has increased its 2024 revenue forecast from the range of $675M-$725M to $690M-$740M, surpassing the estimated $695.74M. Additionally, the company has raised its adjusted EBITDA outlook from $90M-$95M to $95M-$100M.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 11:18 am

CALM

GRTS

PAYX

PLAY

PVH

U.S. stock futures are trading lower, with focus on Paychex, PVH, Dave & Buster's, Gritstone bio, and Cal-Maine Foods due to earnings reports and financial forecasts. Paychex is expected to report earnings of $1.37 per share, while PVH reported higher than expected Q4 results but anticipates a revenue decline. Dave & Buster's and Cal-Maine are also set to report their earnings, and Gritstone bio announced a $32.5 million public offering.

Portfolio Pulse from Avi Kapoor

April 02, 2024 | 11:14 am